Why is this a big problem for the Life Sciences industry?
Instrument manufacturers are constantly evolving and improving the instruments they provide to pharmaceutical and research organisations, then decommissioning instruments that are “end of life” and no longer supported.
Continuing to use end of life systems is a highly risky strategy for any organisation, yet so many companies do it.
In this video, we explore some of the problems that the industry faces.
How end of life system scenarios might affect you
Here are a few scenarios where life sciences organisations need to consider the impact end of life systems have on their data
Isolated systems that are already end of life
End of life and decommissioned systems
Systems reaching end of life
The challenge facing Pharma and research organisations
Can you still access your valuable data?
The Life Sciences industry and science in general has always been a large data producer - how do you ensure that you can access and use all of this valuable data if the instruments you use to collect such data are no longer supported by the instrument manufacturer? In this video we describe some of the challenges in the industry.Take our online risk questionnaire